Component: (Network and Table)
Network
00500 - Statement - Consolidated Statements of Cash Flows
(http://www.skilledhealthcare.com/role/StatementConsolidatedStatementsOfCashFlows)
Table(Implied)
Slicers (applies to each fact value in each table cell)
Reporting Entity [Axis]0001351051 (http://www.sec.gov/CIK)
CONSOLIDATED STATEMENTS OF CASH FLOWSPeriod [Axis]
2016-01-01 - 2016-12-31
2015-01-01 - 2015-12-31
2014-01-01 - 2014-12-31
CONSOLIDATED STATEMENTS OF CASH FLOWS
 
 
 
Cash Flows from Operating Activities
 
 
 
Net loss
(118,051,000) 
(526,768,000) 
(251,529,000) 
Adjustments to reconcile net loss to net cash provided by operating activities:
 
 
 
Non-cash interest and leasing arrangements, net
90,227,000  
93,800,000  
86,073,000  
Other non-cash gains and charges, net
(202,070,000) 
(1,063,000) 
3,947,000  
Share based compensation
8,414,000  
28,472,000  
 
Depreciation and amortization
254,459,000  
237,763,000  
196,192,000  
Provision for losses on accounts receivable
107,815,000  
100,521,000  
78,552,000  
Equity in net (income) loss of unconsolidated affiliates
(3,286,000) 
(2,139,000) 
416,000  
Provision (benefit) for deferred taxes
7,142,000  
164,750,000  
(58,293,000) 
Long-lived asset impairment
35,431,000  
28,546,000  
31,399,000  
Loss on early extinguishment of debt
13,174,000  
130,000  
1,133,000  
Changes in assets and liabilities:
 
 
 
Accounts receivable
(170,126,000) 
(144,624,000) 
(33,568,000) 
Accounts payable and other accrued expenses and other
45,232,000  
29,230,000  
53,330,000  
Net cash provided by operating activities
68,361,000  
 
8,618,000  
 
107,652,000  
 
Cash Flows from Investing Activities
 
 
 
Capital expenditures
(93,118,000) 
(85,723,000) 
(70,987,000) 
Purchases of marketable securities
(52,554,000) 
(83,916,000) 
(30,449,000) 
Proceeds on maturity or sale of marketable securities
72,767,000  
41,314,000  
30,188,000  
Net change in restricted cash and equivalents
22,183,000  
10,269,000  
(24,405,000) 
Sale of investment in joint venture
6,460,000  
26,358,000  
 
Purchases of inpatient assets, net of cash acquired
(108,299,000) 
(167,272,000) 
(1,878,000) 
Sales of assets
150,675,000  
3,738,000  
5,227,000  
Restricted deposits
(13,473,000) 
  
Investments in joint venture
(536,000) 
(392,000) 
(2,309,000) 
Other, net
3,107,000  
2,140,000  
(1,062,000) 
Net cash used in investing activities
(12,788,000) 
 
(253,484,000) 
 
(95,675,000) 
 
Cash Flows from Financing Activities
 
 
 
Borrowings under revolving credit facility
817,000,000  
864,500,000  
603,500,000  
Repayments under revolving credit facility
(787,150,000) 
(756,000,000) 
(549,000,000) 
Proceeds from issuance of long-term debt
416,161,000  
495,201,000  
960,000  
Proceeds from tenant improvement draws under lease arrangements
5,651,000  
2,920,000  
6,087,000  
Repayment of long-term debt
(500,101,000) 
(357,716,000) 
(17,946,000) 
Debt issuance costs
(14,524,000) 
(19,193,000) 
(7,916,000) 
Distributions to noncontrolling interests and stockholders
(2,745,000) 
(10,875,000) 
(21,527,000) 
Issuance of stock
 
24,000  
 
Net cash (used in) provided by financing activities
(65,708,000) 
 
218,861,000  
 
14,158,000  
 
Net decrease in cash and cash equivalents
(10,135,000) 
 
(26,005,000) 
 
26,135,000  
 
Beginning of period
61,543,000  
87,548,000  
61,413,000  
End of period
51,408,000  
 
61,543,000  
 
87,548,000  
 
Supplemental disclosure of cash flow information
 
 
 
Interest paid
445,959,000  
416,163,000  
369,124,000  
Net taxes (refunded) paid
(10,270,000) 
20,893,000  
2,408,000  
Non-cash investing and financing activities:
 
 
 
Capital leases incurred
 
56,766,000  
13,096,000  
Capital leases reduced
(70,997,000) 
  
Financing obligations reduced
(257,101,000) 
  
Financing obligations incurred
 
83,989,000  
80,284,000  
Assumption of long-term debt, net of reclass
4,772,000  
436,887,000  
 
Financing obligation assets
(40,876,000)